SCHEMBL23849352

SCHEMBL23849352

CNC(CO[N+](=O)[O-])O[N+](=O)[O-]

nearest known ligand 0.55

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1244882 0.71 ALDH1A1 (0.37) ALDH1A1
SCHEMBL1244609 0.71 ALDH1A1 (0.37) ALDH1A1
SCHEMBL989882 0.71 ALDH1A1 (0.37) ALDH1A1
SCHEMBL4961745 0.71 ALDH1A1 (0.30) ALDH1A1
Tetranitrin SCHEMBL16541075 0.70 ALDH1A1 (0.40) ALDH1A1
Erythrityl Tetranitrate SCHEMBL1816345 0.70 ALDH1A1 (0.40) ALDH1A1
Nitroglycerin SCHEMBL15421 0.70 PTGS2 (0.40) ALDH1A1
Erythrityl Tetranitrate SCHEMBL119876 0.70 ALDH1A1 (0.40) ALDH1A1
Tetranitrin SCHEMBL613474 0.70 ALDH1A1 (0.40) ALDH1A1
Nitroglycerin SCHEMBL920644 0.70 PTGS2 (0.40) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021231582-A1 NITRO-AMINOADAMANTANE COMPOUNDS FOR THE TREATMENT OF NEGATIVE SYMPTOMS AND COGNITIVE IMPAIRMENT ASSOCIATED WITH SCHIZOPHRENIA EUMENTIS THERAPEUTICS, INC. (US) 2021-11-18 WO disclosed
WO-2021188864-A1 NITRO-AMINOADAMANTANE COMPOUNDS FOR THE TREATMENT OF BETACORONAVIRUS INFECTIONS EUMENTIS THERAPEUTICS, INC. (US) 2021-09-23 WO disclosed